Viewing Study NCT06484868


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-02-03 @ 12:22 PM
Study NCT ID: NCT06484868
Status: RECRUITING
Last Update Posted: 2025-07-03
First Post: 2024-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Sponsor: Amryt Pharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Partial Lipodystrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metreleptin View